title: Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.
abstract: Proteins can exist as multiple proteoformsin vivo, as a result of alternative splicing and single-nucleotide polymorphisms (SNPs), as well as posttranslational processing. To address their clinical significance in a context of diagnostic information, proteoforms require a more in-depth analysis. Mass spectrometric immunoassays (MSIA) have been devised for studying structural diversity in human proteins. MSIA enables protein profiling in a simple and high-throughput manner, by combining the selectivity of targeted immunoassays, with the specificity of mass spectrometric detection. MSIA has been used for qualitative and quantitative analysis of single and multiple proteoforms, distinguishing between normal fluctuations and changes related to clinical conditions. This mini review offers an overview of the development and application of mass spectrometric immunoassays for clinical and population proteomics studies. Provided are examples of some recent developments, and also discussed are the trends and challenges in mass spectrometry-based immunoassays for the next-phase of clinical applications.
authors.affiliation: The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. olgica.trenchevska@asu.edu.
authors.forename: Olgica
authors.initials: O
authors.lastname: Trenchevska
authors.affiliation: The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. randal.nelson@asu.edu.
authors.forename: Randall W
authors.initials: RW
authors.lastname: Nelson
authors.affiliation: The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. dobrin.nedelkov@asu.edu.
authors.forename: Dobrin
authors.initials: D
authors.lastname: Nedelkov
keywords: biomarkers; immunoaffinity; mass spectrometry; posttranslational modifications; top-down analysis